JN

Julian Nikolchev

Sr VP Corporate Development & Ventures at Intuitive

Portola Valley, California

Invests in

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Education

Work Experience

2019 - 2024

  • Sr VP Corprate Development & Strategy; President, Intuitive Ventures,

    2019 - 2024

2016 - 2024

  • Member Board Of Directors

    2016 - 2024

    Zibrio is an early stage digital health company, commercializing certified space technology originally used on astronauts upon return from space flight. The company is dedicated to advancing novel biometrics for human balance.

2011 - 2024

  • Board Observer

    2011 - 2024

    Neocis is transforming dental implant surgery with advanced robotics. The company is focused on enhancing dental surgeons’ capabilities and advancing patient care through the latest technology. Work closely with Founder and CEO to raise financing. Assist with commercialization strategies. Compensation Committee Member.

  • Member of the Board

    2018 - 2020

    Escala Medical is a medical device start up with the mission of developing the first minimally invasive, incision-free repair solutions for women with Pelvic Organ Prolapse (PoP). Invented by highly experienced surgeons, Escala’s device repairs prolapse in a safe and quick procedure with minimal patient discomfort. Escala is supported by the Trendlines Group and the Israeli Authority of Innovation.

  • Member Board Of Directors

    2018 - 2019

    Neptune Medical is a lean and innovative Silicon Valley start-up focused on commercializing high clinical value devices for gastroenterology and other applications

  • X-President and CEO, Currently a Member of the Board

    2015 - 2018

    Dextera Surgical Inc. engages in the design, manufacture, and marketing of proprietary automated anastomotic systems used by cardiac surgeons to perform coronary bypass surgery and is commercializing and developing its MicroCutter 5/80 based on its proprietary ‘staple-on-a-strip’ technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons. Since Dextera's assets have been sold to Aesculap, I have relinquished my CEO position and remain a Board Member.

2015 - 2016

  • Venture Partner

    2015 - 2016

    NanoDimension invests in companies that use break-through nanotechnology to solve critical problems of today’s society and helps them become global leaders in their respective sector.

2006 - 2014

  • Founder and CTO

    2011 - 2014

    Developed the most advanced and innovative suite of products for hip arthroscopy (a minimally invasive procedure to treat early hip pain).

  • Founder and CEO

    2006 - 2011

  • Venture Partner

    2007 - 2009

2003 - 2007

  • Founder and CEO

    2003 - 2007